🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Protoacoustic Imaging For 3D Mapping

Recruitingn/aAges 18 Years - anyAllUniversity of Oklahoma
NCT07832617 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to test a new imaging technology called radioacoustic imaging (RAI) that may help doctors see where radiation is being delivered during proton therapy. During proton therapy, the radiation treatment produces very small sound signals inside the body. This study will use special ultrasound sensors placed on the outside of the body to detect these signals. The information collected may allow researchers to create a picture showing where the radiation dose is being delivered in the body and how much radiation is reaching the treatment area. The goal is to determine whether this technology can safely and accurately measure radiation during proton therapy without requiring any additional procedures or radiation exposure.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients at least \>18years old * Patients referred to OUHSC SCC for SOC PT * Patients receiving treatment for indications where RAI data collection is feasible (e.g., liver and prostate) * Willingness and ability to provide a documented informed consent Exclusion Criteria: * Patients with contraindications for ultrasound coupling (e.g., extensive open wounds or skin conditions at transducer placement sites). * Patients whose treatment plan or setup prevents the practical application of the RAI system without interfering with standard clinical care * Patients with implanted electronic devices (e.g., pacemakers) in the treatment region if there is any concern of device interference, even though the RAI system is passive.
💊

What it tests

  • Radiacoustic Imaging w/Ultrasound.
📍

Where

1 site
OU Health Stephenson Cancer Center
Oklahoma City, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy